122 related articles for article (PubMed ID: 29335738)
1. Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
Enomoto M; Tateishi C; Tsuruta D; Tamori A; Kawada N
Ann Intern Med; 2018 May; 168(9):678-680. PubMed ID: 29335738
[No Abstract] [Full Text] [Related]
2. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
[No Abstract] [Full Text] [Related]
3. Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals.
López Couceiro L; Gómez Domínguez E; Muñoz Gómez R; Castellano Tortajada G; Ibarrola de Andrés C; Fernández Vázquez I
Rev Esp Enferm Dig; 2019 Feb; 111(2):159-161. PubMed ID: 30449122
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.
Takata K; Shakado S; Sakamoto K; Fukuda H; Yamauchi R; Fukuda S; Kunimoto H; Umeda K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Sakisaka S
Clin J Gastroenterol; 2017 Oct; 10(5):459-463. PubMed ID: 28884440
[TBL] [Abstract][Full Text] [Related]
5. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Graf Einsiedel H; Christiansen H; Wiegand J
Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
[No Abstract] [Full Text] [Related]
6. Therapy for hepatitis C--the costs of success.
Hoofnagle JH; Sherker AH
N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
[No Abstract] [Full Text] [Related]
7. Hepatitis C Virus and Schizophrenia: Expanding the Role of the Community Psychiatrist.
Herold S; Freudenreich O
Psychosomatics; 2016; 57(6):634-637. PubMed ID: 27418108
[No Abstract] [Full Text] [Related]
8. Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial.
Øvrehus ALH; Krarup H; Birkemose I; Holm DK; Mössner B; Ernst A; Christensen PB
J Hepatol; 2018 Apr; 68(4):840-842. PubMed ID: 29223370
[No Abstract] [Full Text] [Related]
9. [Interferon free recovery for almost all patients].
Einecke D
MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
[No Abstract] [Full Text] [Related]
10. Assessing a broader user base for new HCV drug.
Sekkides O
Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
[No Abstract] [Full Text] [Related]
11. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
[No Abstract] [Full Text] [Related]
12. Shorter treatments for hepatitis C: another step forward?
Foster GR
Lancet; 2015 Mar; 385(9973):1054-5. PubMed ID: 25591504
[No Abstract] [Full Text] [Related]
13. Hepatitis C Virus Infection in ESKD Patients.
Ladino M; Roth D
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1735-1737. PubMed ID: 30065068
[No Abstract] [Full Text] [Related]
14. Role of Direct-Acting Antivirals in Hepatitis C Virus-Positive Castleman Disease.
Tahir M; Charles L
Am J Ther; 2018; 25(6):e733-e734. PubMed ID: 29557805
[No Abstract] [Full Text] [Related]
15. Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
Parlati L; Sirmai L; Dupuy CA; Glotz D; Pol S
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):e18-e19. PubMed ID: 30293896
[No Abstract] [Full Text] [Related]
16. Are we hopefully very close to the end of HCV?
Tahan V
Turk J Gastroenterol; 2014 Apr; 25(2):230-1. PubMed ID: 25003693
[No Abstract] [Full Text] [Related]
17. Simultaneous targeted therapy for metastatic melanoma and hepatitis C.
Kofler L; Berg C; Kofler K; Geipel A; Lipp HP; Müller A; Eigentler T; Forschner A
J Dtsch Dermatol Ges; 2020 Jan; 18(1):42-43. PubMed ID: 31538700
[No Abstract] [Full Text] [Related]
18. Anti-HCV for porphyria cutanea tarda.
Abdelmaksoud A
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133909
[No Abstract] [Full Text] [Related]
19. [Hope for Cirrhosis Patients with Genotype 1 Hepatitis C Virus Who Failed the Previous Treatment].
Kwon JH
Korean J Gastroenterol; 2015 Aug; 66(2):131-3. PubMed ID: 26513826
[No Abstract] [Full Text] [Related]
20. Drug-Drug Interactions in Patients Co-infected With HCV and HIV.
Nozaki Y; Yanase M; Masaki N
JAMA; 2015 Jul; 314(2):186. PubMed ID: 26172899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
